AI주식인사이트AI Stock Insight
B

일동홀딩스

000230KOSPI

59.0 / 100

Reference Date: 2026-09-08

Financial Score27.5 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers but ROE is below the industry average. Slightly down 3.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Iljung Holdings operates seven business divisions, including pharmaceuticals, advertising, ion water generators, software and medical devices, functional foods, and clinical pharmacology consulting. The company's main revenue comes from pharmaceutical manufacturing and sales (614.94 billion won) and software/medical device development (27.99 billion won), while advertising and ion water generator segments experienced declines compared to the previous year.

Number of Employees

84people

Average Salary

62.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
3.29Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR
0.21Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
7.20Industry Average 8.002.5Point

Below industry avg

Debt Ratio
40.61Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼3.6% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲407.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -12.2% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 6,150Won52-week high 15,81052-week low 5,660
1-month return2.0Point

1m -3.45% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14